Delivery Order SPE2DB22D3010-SPE2DB24FP1UC
Award Date
2/23/24
Potential Completion Date
2/26/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,362.77 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. This delivery order contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this contract, which is not designated as a set-aside. The award is associated with a larger indefinite...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,097.22 contract is for the supply of the specialty pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a potential value of $1,575.18 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies,...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,072.07, is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,412.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceuticals. The contract has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency, with a ceiling value of $1,248.70. The contract has a firm fixed-price pricing type and an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and the parent...
This is a $1,050.12 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML to the Defense Logistics Agency (DLA). The $1,312.65 firm fixed-price delivery order has a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price valued at $2,024.63, with an ultimate completion date of April 2, 2024. The contract provides for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a specialty pharmaceutical product. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,272.27, is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...